Cargando…

The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes

Objective. We studied the prevalence of nonalcoholic fatty liver disease (NAFLD) and its clinical correlates in a population of patients with type 2 diabetes mellitus (T2DM). Methods. Clinical data of 94,577 T2DM patients were retrieved from 160 diabetes clinics in Italy in a standardized format and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forlani, Gabriele, Giorda, Carlo, Manti, Roberta, Mazzella, Natalia, De Cosmo, Salvatore, Rossi, Maria Chiara, Nicolucci, Antonio, Di Bartolo, Paolo, Ceriello, Antonio, Guida, Pietro, Study Group, AMD-Annals
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829721/ https://www.ncbi.nlm.nih.gov/pubmed/27123461 http://dx.doi.org/10.1155/2016/2931985

Ejemplares similares

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions
por: Gentile, Sandro, et al.
Publicado: (2018)

Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative
por: De Cosmo, Salvatore, et al.
Publicado: (2016)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
por: Mirijello, Antonio, et al.
Publicado: (2018)

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
por: Viazzi, Francesca, et al.
Publicado: (2017)

Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018)

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018)

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2018)

Metabolic syndrome, serum uric acid and renal risk in patients with T2D
por: Viazzi, Francesca, et al.
Publicado: (2017)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2017)

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2023)

Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
por: Nicolucci, Antonio, et al.
Publicado: (2019)

Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
por: Gentile, Sandro, et al.
Publicado: (2017)

Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study
por: Russo, Giuseppina T., et al.
Publicado: (2014)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Diabetes Interactive Diary: A New Telemedicine System Enabling Flexible Diet and Insulin Therapy While Improving Quality of Life: An open-label, international, multicenter, randomized study
por: Rossi, Maria C.E., et al.
Publicado: (2010)

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD
por: Duvnjak, Marko, et al.
Publicado: (2019)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

076 Risk of severe COVID-19 associated with immune-modifying drugs: data from PsoProtect and Global Rheumatology Alliance registries
por: Group, P Study, et al.
Publicado: (2022)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

NAFLD and liver transplantation: Disease burden, current management and future challenges
por: Burra, Patrizia, et al.
Publicado: (2020)

Modelling NAFLD disease burden in four Asian regions—2019‐2030
por: Estes, Chris, et al.
Publicado: (2020)

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
por: Paik, James M., et al.
Publicado: (2021)

Book Review: Scientific Method: How Science Works, Fails to Work and Pretends to Work
por: Amd, Micah
Publicado: (2018)

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
por: Giorda, Carlo Bruno, et al.
Publicado: (2020)

Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative
por: Russo, Giuseppina T., et al.
Publicado: (2022)

Baseline Quality-of-Care Data From a Quality-Improvement Program Implemented by a Network of Diabetes Outpatient Clinics
por: Rossi, Maria C.E., et al.
Publicado: (2008)

Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study
por: Pintaudi, Basilio, et al.
Publicado: (2021)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
por: De Berardis, Giorgia, et al.
Publicado: (2007)

Ctf2 design report: The CLIC Test Facility - CTF2 A two-beam test accelerator for linear collider studies The CLIC Study Group
por: CLIC Study Group
Publicado: (1996)

The Role of Metformin in the Management of NAFLD
por: Mazza, Angela, et al.
Publicado: (2012)

Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study
por: Nicolucci, Antonio, et al.
Publicado: (2021)

Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes: A cross-sectional observational study from the AMD Annals initiative
por: Rossi, Maria Chiara, et al.
Publicado: (2013)

Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus
por: Russo, Giuseppina, et al.
Publicado: (2015)

Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative
por: Manicardi, Valeria, et al.
Publicado: (2016)

Molecular Mechanisms of NAFLD in Metabolic Syndrome
por: Martins, Maria João, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2urbh45vl6vf7kamjgpt141l3i